Authors: Bertilsson G, Patrone C, Zachrisson O, Andersson A, Dannaeus K, Heidrich J, Kortesmaa J, Mercer A, Nielsen E, Rnnholm H, Wikstrm L
the acquisition, analysis, or interpretation of data for the work (K.S.B., J.L.P., S.W., J.L., M.L.H., C.K.M., T.C.)
Starting with lower doses helped reduce the severity
Back Cordes, EH (2020) 'Chapter 10: Diabetes breakthroughs: Thornberry and Weber in EH Cordes, Hallelujah Moments
External resources Triple-Hormone-Receptor Agonist Retatrutide for Obesity, Phase 2 Trial (NEJM) Tirzepatide Once Weekly for the Treatment of Obesity, SURMOUNT-1 (NEJM) Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease (Nature Medicine) In case I do not see you, good afternoon, good evening, and good night
NEJM 2023 (retatrutide)